Von Willebrand Type III Disease in Obstetric Patient
Published
Sep 30, 2019
Almetrics
Dimensions
Google Scholar
Angelica María Toro Cubides
https://orcid.org/0000-0002-7906-778X
Ana Sofía Aguilar Posada
https://orcid.org/0000-0002-7906-778X
Ana Sofía Aguilar Posada
##plugins.themes.bootstrap3.article.details##
Abstract
Von Willebrand disease caused by deficiency of this coagulation factor, hereditary and of greater prevalence in women, is manifested mainly with long menstruals bleeding. This pathology in pregnancy by the associated physiological changes becomes a high-risk pregnancy that we should diagnose and be attentive to their behaviors in both the pre and postpartum; A case report is included in the San Ignacio University Hospital, showing its clear behavior as described in the literature of this rare pathology in our context.
Keywords
Blood coagulation disorder, uterine bleeding, obstetric delivery, postpartum haemorrhageTranstorno de la coagulación sanguinea, Henorragia Uterina, parto obstétrico, Hemorragia post parto.
References
Referencias
1. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Schults J, Abshire TC. Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr. 1993; 123:893-898.
2. Bloom AL. Von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc. 1991;66:743-51.
3. Nilsson IM. Von Willebrand's disease from. 1926-1983. Scand J Haematol. 1984;33:S21-43.
4. Von Willebrand EA. Hereditar pseudohemofili. Finska Lakarsallskapets Handl. 1926;67:7-112.
5. Lipe BC, Dumas MA, Ornstein DL. Von Willebrand disease in pregnancy. Hematol Oncol Clin North Am. 2011;25(2):335-58. https://doi.org/10.1016/j.hoc.2011.01.006
6. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4(10):2103-114. https://doi.org/10.1111/j.1538-7836.2006.02146.x
7. Duflos-Cohade C, Bernier MO, Thibaud E. Métrorragies pubertaires et troubles de la coagulation. Rev Int Pédiatr. 2001;32:15-8.
8. Ruggeri ZM. New insights into the mechanism of platelet adhesion and aggregation. Semin Hematol. 1994;31:229-39.
9. Hassan MI, Saxena A, Ahmad F. Structure and function of von Willebrand factor. Blood Coagul Fibrinolysis. 2012;23(1):11-22.
10. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-9.
11. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Eng J Med. 1984;311:1084-98.
12. Hoyer LW. Pseudo-von Willebrand's disease. N Eng J Med. 1982;306:360-2.
13. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril. 2005;84:1352-9.
14. Bowman M, Mundell G, Grabell J, Hopman WM, Rapson D, Lillicrap D, James P. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost. 2008. https://doi.org/10.1111/j.1538-7836.2008.03182.x
15. Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost. 2007;5 Suppl 1:157-66.
16. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160.
17. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. AJCP 1995;104:264-71.
18. Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA; Association of Hemophilia Clinic Directors of Canada. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost. 2002;87:224-30.
19. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171.
20. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol. 2001;14:381-99.
21. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2005;11(5-6):409-14.
22. Jones BP, Bell EA, Maroof M. Epidural labor analgesia in a parturient with von Willebrand´s disease type IIA and severe preeclampsia. Anesthesiology. 1999;90:1219-20.
23. Kujovich JL. Von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246-53.
24. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol. 2001;14(2):381-99.
25. O’Riordan MN. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obst Gynaecol. 2003;17(3):385-96.
26. Milaskievicz RM, Holcroft A, Letsky E. Epidural anaesthesia and von Willebrand's disease. Anaesthesia. 1990;45:462-4.
27. Altisent C. Coagulopatías congénitas y gestación. En: Salinas R, Argente I, editores. Abordaje práctico de las alteraciones hematológicas en la mujer embarazada y en el neonato. Madrid: Acción Médica; 2004. p. 115-32. 30
28. Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246-53.
29. Duerbeck NB, Chaffin DG, Coney P. Platelet and hemorragic disorders associated with pregnancy: a review. Part II. Obstet Gynecol Surv. 1997;52:585-96.
30. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril. 2005;84:1352-9.
31. Castaman G, Goodeve A, Eikenboom J, on behalf of the European Group on von Willebrand disease. Principles of care for the diagnosis and treatment of von Willebrand disease. Hematol. 2013;98(5):667-74. https://doi.org/10.3324/haematol.2012.077263
32. Pacheco LD, Constantine MM, Saade GR, Mucowski S, Hankins G, Sciscione A. Von Willebrand disease and pregnancy: A practical approach for the diagnosis and treatment. Am J Obstet Gynecol. 2010 Sep;203(3):194-200. https://doi.org/10.1016/j.ajog.2010.02.036.
33. Pasi KJ, Collins PW, Keeling DM, et al. Management of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors’ Organization. Haemophilia. 2004;10:218-31.
34. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: A report of 24 pregnancies and a review of the literature. Haemophilia. 1995;1:140-4.
35. Roque H, Funai E, Lockwood CJ. von Willebrand disease and pregnancy. J Matern Fetal Med. 2000;9: 257-266.
1. Werner EJ, Broxson EH, Tucker EL, Giroux DS, Schults J, Abshire TC. Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr. 1993; 123:893-898.
2. Bloom AL. Von Willebrand factor: clinical features of inherited and acquired disorders. Mayo Clin Proc. 1991;66:743-51.
3. Nilsson IM. Von Willebrand's disease from. 1926-1983. Scand J Haematol. 1984;33:S21-43.
4. Von Willebrand EA. Hereditar pseudohemofili. Finska Lakarsallskapets Handl. 1926;67:7-112.
5. Lipe BC, Dumas MA, Ornstein DL. Von Willebrand disease in pregnancy. Hematol Oncol Clin North Am. 2011;25(2):335-58. https://doi.org/10.1016/j.hoc.2011.01.006
6. Sadler JE, Budde U, Eikenboom JC, Favaloro EJ, Hill FG, Holmberg L, Federici AB. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost. 2006;4(10):2103-114. https://doi.org/10.1111/j.1538-7836.2006.02146.x
7. Duflos-Cohade C, Bernier MO, Thibaud E. Métrorragies pubertaires et troubles de la coagulation. Rev Int Pédiatr. 2001;32:15-8.
8. Ruggeri ZM. New insights into the mechanism of platelet adhesion and aggregation. Semin Hematol. 1994;31:229-39.
9. Hassan MI, Saxena A, Ahmad F. Structure and function of von Willebrand factor. Blood Coagul Fibrinolysis. 2012;23(1):11-22.
10. Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand's disease. Blood. 1987;69:454-9.
11. George JN, Nurden AT, Phillips DR. Molecular defects in interactions of platelets with the vessel wall. N Eng J Med. 1984;311:1084-98.
12. Hoyer LW. Pseudo-von Willebrand's disease. N Eng J Med. 1982;306:360-2.
13. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril. 2005;84:1352-9.
14. Bowman M, Mundell G, Grabell J, Hopman WM, Rapson D, Lillicrap D, James P. Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease. J Thromb Haemost. 2008. https://doi.org/10.1111/j.1538-7836.2008.03182.x
15. Rodeghiero F, Tosetto A, Castaman G. How to estimate bleeding risk in mild bleeding disorders. J Thromb Haemost. 2007;5 Suppl 1:157-66.
16. Sadler JE, Mannucci PM, Berntorp E, et al. Impact, diagnosis and treatment of von Willebrand disease. Thromb Haemost. 2000;84:160.
17. Favaloro EJ, Facey D, Grispo L. Laboratory assessment of von Willebrand factor. AJCP 1995;104:264-71.
18. Lillicrap D, Poon MC, Walker I, Xie F, Schwartz BA; Association of Hemophilia Clinic Directors of Canada. Efficacy and safety of the factor VIII/von Willebrand factor concentrate, haemate-P/humate-P: Ristocetin cofactor unit dosing in patients with von Willebrand disease. Thromb Haemost. 2002;87:224-30.
19. Nichols WL, Hultin MB, James AH, et al. von Willebrand disease (VWD): Evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA). Haemophilia. 2008;14:171.
20. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol. 2001;14:381-99.
21. Brenner B. Haemostatic changes in pregnancy. Thromb Res. 2005;11(5-6):409-14.
22. Jones BP, Bell EA, Maroof M. Epidural labor analgesia in a parturient with von Willebrand´s disease type IIA and severe preeclampsia. Anesthesiology. 1999;90:1219-20.
23. Kujovich JL. Von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246-53.
24. Kouides PA. Obstetric and gynaecological aspects of von Willebrand disease. Best Pract Res Clin Haematol. 2001;14(2):381-99.
25. O’Riordan MN. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obst Gynaecol. 2003;17(3):385-96.
26. Milaskievicz RM, Holcroft A, Letsky E. Epidural anaesthesia and von Willebrand's disease. Anaesthesia. 1990;45:462-4.
27. Altisent C. Coagulopatías congénitas y gestación. En: Salinas R, Argente I, editores. Abordaje práctico de las alteraciones hematológicas en la mujer embarazada y en el neonato. Madrid: Acción Médica; 2004. p. 115-32. 30
28. Kujovich JL. von Willebrand disease and pregnancy. J Thromb Haemost. 2005;3:246-53.
29. Duerbeck NB, Chaffin DG, Coney P. Platelet and hemorragic disorders associated with pregnancy: a review. Part II. Obstet Gynecol Surv. 1997;52:585-96.
30. Kadir RA, Lukes AS, Kouides PA, Fernandez H, Goudemand J. Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril. 2005;84:1352-9.
31. Castaman G, Goodeve A, Eikenboom J, on behalf of the European Group on von Willebrand disease. Principles of care for the diagnosis and treatment of von Willebrand disease. Hematol. 2013;98(5):667-74. https://doi.org/10.3324/haematol.2012.077263
32. Pacheco LD, Constantine MM, Saade GR, Mucowski S, Hankins G, Sciscione A. Von Willebrand disease and pregnancy: A practical approach for the diagnosis and treatment. Am J Obstet Gynecol. 2010 Sep;203(3):194-200. https://doi.org/10.1016/j.ajog.2010.02.036.
33. Pasi KJ, Collins PW, Keeling DM, et al. Management of von Willebrand disease: A guideline from the UK Haemophilia Centre Doctors’ Organization. Haemophilia. 2004;10:218-31.
34. Ramsahoye BH, Davies SV, Dasani H, Pearson JF. Obstetric management in von Willebrand's disease: A report of 24 pregnancies and a review of the literature. Haemophilia. 1995;1:140-4.
35. Roque H, Funai E, Lockwood CJ. von Willebrand disease and pregnancy. J Matern Fetal Med. 2000;9: 257-266.
How to Cite
Toro Cubides, A. M., & Aguilar Posada, A. S. (2019). Von Willebrand Type III Disease in Obstetric Patient. Universitas Medica, 60(4), 1–9. https://doi.org/10.11144/Javeriana.umed60-4.vonw
Issue
Section
Case Reports